Boston Scientific Corporation vs F5 Inc — how do they compare? Boston Scientific Corporation trades at $51.1 (market cap $74.19B), while F5 Inc trades at $414 (market cap $23.44B). The key difference: Boston Scientific Corporation is far larger — about 3.2× F5 Inc's market cap, and F5 Inc is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | FFIV | |
|---|---|---|
Market Cap | $74.19B | $23.44B |
Sector | Health | Technology |
52-Week High | $108.14 | $431.26 |
52-Week Low | $42.63 | $223.99 |
Enterprise Value | $86.27B | $22.08B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →